首页> 外文期刊>Oncology Research >Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells
【24h】

Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells

机译:miR-147的异位表达抑制结肠癌细胞中干细胞标志物和上皮间过渡(EMT)相关蛋白表达

获取原文
获取原文并翻译 | 示例
       

摘要

Colon cancer is one of the most common cancers in the world. Epithelial-to-mesenchymal transition (EMT) is a crucial step in tumor progression and is also involved in the acquisition of stem cell-like properties. Some miRNAs have been shown to function as either tumor suppressors or oncogenes in colon cancer. Here we investigated the role of miR-147 in the regulation of the stem cell-like traits of colon cancer cells. We observed that miR-147 was downregulated in several colon cancer cell lines, and overexpressed miR-147 decreased the expression of cancer stem cell (CSC) markers OCT4, SOX2, and NANOG in the colon cancer cell lines HCT116 and SW480. Overexpressed miR-147 inhibited EMT by increasing the expression of epithelial markers E-cadherin and alpha-catenin while decreasing the expression of mesenchymal markers fibronectin and vimentin. Moreover, activation of EMT by TGF-beta 1 treatment significantly counteracted the inhibitive effect of miR-147 on the expression of CSC markers OCT4, SOX2, and NANOG, supporting the idea that overexpressing miR-147 inhibited stem cell-like traits by suppressing EMT in colon cancer. In addition, we found that overexpressed miR-147 downregulated the expression of beta-catenin, c-myc, and survivin, which were related to the Wnt/beta-catenin pathway. Moreover, treatment of miR-147 mimic-transfected cells with the Wnt/beta-catenin pathway activator LiCl attenuated the inhibitive effect of the miR-147 mimic on the EMT and stem cell-like traits of colon cancer cells, indicating that ectopic expression of miR-147 inhibited stem cell-like traits in colon cancer cells by suppressing EMT via the Wnt/beta-catenin pathway. In summary, our present study highlighted the crucial role of miR-147 in the inhibition of the stem cell-like traits of colon cancer cells and indicated that miR-147 could be a promising therapeutic target for colon cancer treatment.
机译:结肠癌是世界上最常见的癌症之一。上皮 - 间充质转换(EMT)是肿瘤进展的关键步骤,也是获取干细胞状性质的获取。已经证明了一些miRNA可以作为肿瘤抑制剂或结肠癌的癌基因。在这里,我们调查了miR-147在结肠癌细胞的干细胞状状调节中的作用。我们观察到MiR-147在几种结肠癌细胞系中下调,过表达MiR-147降低了结肠癌细胞系HCT116和SW480中的癌症干细胞(CSC)标记Oct4,Sox2和Nanog的表达。过表达MIR-147通过增加上皮标记物E-钙粘蛋白和α-连环蛋白的表达而抑制EMT,同时降低间充质标志物纤连蛋白和平节素的表达。此外,通过TGF-β1治疗激活EMT的激活显着抵消了miR-147对CSC标记Oct4,Sox2和Nanog表达的抑制作用,支持过度表达MIR-147通过抑制EMT抑制干细胞样特征的想法在结肠癌中。此外,我们发现过表达MIR-147下调了与WNT /β-连环蛋白途径有关的β-catenin,c-myc和survivin的表达。此外,用WNT /β-连环蛋白途径激活剂LiCl处理miR-147模拟转染的细胞,LiCl衰减miR-147模拟在结肠癌细胞的EMT和干细胞样特征上的miR-147模拟的抑制作用,表明异位表达MiR-147通过通过WNT /β-连环蛋白途径抑制EMT来抑制结肠癌细胞中的干细胞状状。总之,我们现在的研究强调了miR-147在抑制结肠癌细胞的抑制性细胞状状性状的抑制中的关键作用,并表明MiR-147可以是结肠癌治疗的有希望的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号